NO20042916L - HIV integrase inhibitorer - Google Patents
HIV integrase inhibitorerInfo
- Publication number
- NO20042916L NO20042916L NO20042916A NO20042916A NO20042916L NO 20042916 L NO20042916 L NO 20042916L NO 20042916 A NO20042916 A NO 20042916A NO 20042916 A NO20042916 A NO 20042916A NO 20042916 L NO20042916 L NO 20042916L
- Authority
- NO
- Norway
- Prior art keywords
- hiv integrase
- integrase inhibitors
- inhibitors
- hiv
- integrase
- Prior art date
Links
- 229940099797 HIV integrase inhibitor Drugs 0.000 title 1
- 239000003084 hiv integrase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C207/00—Compounds containing nitroso groups bound to a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C207/00—Compounds containing nitroso groups bound to a carbon skeleton
- C07C207/04—Compounds containing nitroso groups bound to a carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/20—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/63—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton
- C07C255/64—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33967401P | 2001-12-12 | 2001-12-12 | |
| PCT/US2002/039093 WO2003052410A1 (fr) | 2001-12-13 | 2002-12-06 | Procede et appareil destines a un compteur de mesure des unites btu sans combustion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042916L true NO20042916L (no) | 2004-09-10 |
Family
ID=23330105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042916A NO20042916L (no) | 2001-12-12 | 2004-07-09 | HIV integrase inhibitorer |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6777440B2 (fr) |
| EP (1) | EP1467695A2 (fr) |
| JP (1) | JP2005515206A (fr) |
| KR (1) | KR20040065251A (fr) |
| CN (1) | CN1617849A (fr) |
| AR (1) | AR037770A1 (fr) |
| AU (1) | AU2002366604A1 (fr) |
| BR (1) | BR0214842A (fr) |
| CA (1) | CA2469592C (fr) |
| CO (1) | CO5590909A2 (fr) |
| HR (1) | HRP20040534A2 (fr) |
| HU (1) | HUP0402675A2 (fr) |
| IL (1) | IL162325A0 (fr) |
| IS (1) | IS7305A (fr) |
| MX (1) | MXPA04005623A (fr) |
| NO (1) | NO20042916L (fr) |
| NZ (1) | NZ533413A (fr) |
| PE (1) | PE20030763A1 (fr) |
| PL (1) | PL370664A1 (fr) |
| RU (1) | RU2284315C2 (fr) |
| TW (1) | TWI252757B (fr) |
| UY (1) | UY27577A1 (fr) |
| WO (1) | WO2003049690A2 (fr) |
| ZA (1) | ZA200404628B (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7094909B2 (en) | 2001-06-11 | 2006-08-22 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| US7169932B2 (en) | 2001-06-11 | 2007-01-30 | Pfizer Inc. | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
| HN2002000136A (es) | 2001-06-11 | 2003-07-31 | Basf Ag | Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis |
| PA8586801A1 (es) | 2002-10-31 | 2005-02-04 | Pfizer | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso |
| CA2513141A1 (fr) | 2003-01-27 | 2004-08-12 | Pfizer Inc. | Inhibiteurs de vih-integrase, compositions pharmaceutiques et methodes d'utilisation desdits inhibiteurs |
| US6890942B2 (en) * | 2003-05-16 | 2005-05-10 | Bristol-Myers Squibb Company | Acyl sulfonamides as inhibitors of HIV integrase |
| US7776863B2 (en) * | 2004-03-24 | 2010-08-17 | Bristol-Myers Squibb Company | Methods of treating HIV infection |
| US20050215544A1 (en) * | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
| MXPA06012342A (es) | 2004-04-26 | 2007-01-17 | Pfizer | Inhibidores de la enzima integrasa del virus de la inmunodeficiencia humana. |
| WO2005103003A2 (fr) | 2004-04-26 | 2005-11-03 | Pfizer Inc. | Inhibiteurs de l'enzyme integrase du vih |
| US7507838B2 (en) * | 2004-09-01 | 2009-03-24 | Bristol-Myers Squibb Company | Process for the preparation of Z-5-carboxymethylene-1,3-dioxolan-4-ones |
| US20060058286A1 (en) * | 2004-09-16 | 2006-03-16 | Mark Krystal | Methods of treating HIV infection |
| WO2007086584A1 (fr) * | 2006-01-30 | 2007-08-02 | Meiji Seika Kaisha, Ltd. | NOUVEL INHIBITEUR DE FabK ET DE FabI/K |
| WO2008004100A2 (fr) | 2006-07-05 | 2008-01-10 | Pfizer Products Inc. | Composés thérapeutiques |
| PT2364293E (pt) * | 2008-12-05 | 2013-04-26 | Syngenta Participations Ag | Novas pirazol-4-n-alcoxicarboxamidas como microbiocidas |
| US20120316161A1 (en) | 2009-12-23 | 2012-12-13 | Katholieke Universiteit Leuven | Novel antiviral compounds |
| US8283366B2 (en) | 2010-01-22 | 2012-10-09 | Ambrilia Biopharma, Inc. | Derivatives of pyridoxine for inhibiting HIV integrase |
| CA2817896A1 (fr) | 2010-11-15 | 2012-05-24 | Viiv Healthcare Uk Limited | Inhibiteurs de la replication du vih |
| EP2640705A2 (fr) | 2010-11-15 | 2013-09-25 | Katholieke Universiteit Leuven | Nouveaux composés antiviraux |
| CN104245660A (zh) * | 2012-04-26 | 2014-12-24 | 拜尔农科股份公司 | 制备n-(5-氯-2-异丙基苄基)-环丙胺的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR029304A1 (es) * | 1998-06-26 | 2003-06-25 | Daiichi Seiyaku Co | DERIVADOS DE PROPIONILO SUSTITUIDOS, PRODUCTO FARMACEUTICO, USO PARA LA FABRICACION DE UNA COMPOSICION FARMACEUTICA PARA LA PREVENCION Y/O TRATAMIENTO DE HIPERCOLESTEROLEMIA, HIPERLIPEMIA O ARTERIOESCLEROSIS, COMPOSICIoN FARMACÉUTICA Y COMPUESTOS INTERMEDIARIOS |
-
2002
- 2002-12-06 JP JP2003550741A patent/JP2005515206A/ja not_active Withdrawn
- 2002-12-06 IL IL16232502A patent/IL162325A0/xx unknown
- 2002-12-06 NZ NZ533413A patent/NZ533413A/en unknown
- 2002-12-06 BR BR0214842-0A patent/BR0214842A/pt not_active Withdrawn
- 2002-12-06 US US10/313,058 patent/US6777440B2/en not_active Expired - Lifetime
- 2002-12-06 MX MXPA04005623A patent/MXPA04005623A/es unknown
- 2002-12-06 RU RU2004119963/04A patent/RU2284315C2/ru not_active IP Right Cessation
- 2002-12-06 WO PCT/US2002/039092 patent/WO2003049690A2/fr not_active Application Discontinuation
- 2002-12-06 HU HU0402675A patent/HUP0402675A2/hu unknown
- 2002-12-06 CA CA002469592A patent/CA2469592C/fr not_active Expired - Fee Related
- 2002-12-06 TW TW091135471A patent/TWI252757B/zh not_active IP Right Cessation
- 2002-12-06 PL PL02370664A patent/PL370664A1/xx not_active Application Discontinuation
- 2002-12-06 EP EP02804741A patent/EP1467695A2/fr not_active Withdrawn
- 2002-12-06 AU AU2002366604A patent/AU2002366604A1/en not_active Abandoned
- 2002-12-06 KR KR10-2004-7009018A patent/KR20040065251A/ko not_active Application Discontinuation
- 2002-12-06 CN CNA028279700A patent/CN1617849A/zh active Pending
- 2002-12-10 AR ARP020104777A patent/AR037770A1/es not_active Application Discontinuation
- 2002-12-11 UY UY27577A patent/UY27577A1/es not_active Application Discontinuation
- 2002-12-12 PE PE2002001198A patent/PE20030763A1/es not_active Application Discontinuation
-
2004
- 2004-06-09 CO CO04054295A patent/CO5590909A2/es not_active Application Discontinuation
- 2004-06-10 IS IS7305A patent/IS7305A/is unknown
- 2004-06-10 ZA ZA200404628A patent/ZA200404628B/en unknown
- 2004-06-11 HR HR20040534A patent/HRP20040534A2/hr not_active Application Discontinuation
- 2004-07-09 NO NO20042916A patent/NO20042916L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2469592A1 (fr) | 2003-06-19 |
| ZA200404628B (en) | 2005-09-01 |
| CO5590909A2 (es) | 2005-12-30 |
| IL162325A0 (en) | 2005-11-20 |
| US20030176495A1 (en) | 2003-09-18 |
| WO2003049690A3 (fr) | 2004-01-22 |
| EP1467695A2 (fr) | 2004-10-20 |
| MXPA04005623A (es) | 2004-12-06 |
| CN1617849A (zh) | 2005-05-18 |
| AU2002366604A1 (en) | 2003-06-23 |
| CA2469592C (fr) | 2005-08-23 |
| BR0214842A (pt) | 2005-01-11 |
| UY27577A1 (es) | 2003-07-31 |
| RU2004119963A (ru) | 2006-01-10 |
| NZ533413A (en) | 2006-09-29 |
| PL370664A1 (en) | 2005-05-30 |
| US6777440B2 (en) | 2004-08-17 |
| KR20040065251A (ko) | 2004-07-21 |
| TW200301105A (en) | 2003-07-01 |
| PE20030763A1 (es) | 2003-09-13 |
| WO2003049690A2 (fr) | 2003-06-19 |
| HRP20040534A2 (en) | 2005-04-30 |
| TWI252757B (en) | 2006-04-11 |
| JP2005515206A (ja) | 2005-05-26 |
| IS7305A (is) | 2004-06-10 |
| HUP0402675A2 (hu) | 2005-03-29 |
| AR037770A1 (es) | 2004-12-01 |
| RU2284315C2 (ru) | 2006-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003248872A8 (en) | Hiv integrase inhibitors | |
| DE60211317D1 (de) | Rho-kinase inhibitoren | |
| DE60218138D1 (de) | Rho-kinase inhibitoren | |
| DK1564210T3 (da) | 4-Oxoquinolinforbindelser og anvendelse deraf som HIV-integraseinhibitorer | |
| CY2015028I1 (el) | Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης | |
| DE60234125D1 (de) | E inhibitoren | |
| NO20041293L (no) | Alkyn-aryl-fosfodiesterase-4-inhibitorer | |
| IS7305A (is) | HIV-integrasa tálmar | |
| ATE286049T1 (de) | Pyridazinonaldose reductase inhibitoren | |
| NO20031672D0 (no) | Aza- og polyaza-naftalenylkarboksamider for anvendelse som HIV-integraseinhibitorer | |
| NO20034044L (no) | Metallproteinase-inhibitorer | |
| EE200300416A (et) | Ravimvorm | |
| NO20042121D0 (no) | Kinolinforbindelse | |
| NO20034032L (no) | Metallproteinase-inhibitorer | |
| NO20035315D0 (no) | Farmasöytiske kombinasjoner | |
| AP2005003451A0 (en) | HIV integrase inhibitors. | |
| DE60239456D1 (de) | Amplifizierungsverfahren | |
| AU6989501A (en) | Hiv integrase inhibitors | |
| DK1387842T3 (da) | Bredspektrede 2-amino-benzoxazolsulfonamid-HIV-protease-inhibitorer | |
| ITMI20010954A0 (it) | Procedimento di iodurazione | |
| NO20012126D0 (no) | HIV-vaksine | |
| SE0100582D0 (sv) | Point | |
| ITBZ20010009U1 (it) | Tavolo | |
| ITTS20010009U1 (it) | Lettino massotrazione | |
| ITTS20010009A1 (it) | Lettino massotrazione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |